-
Experience from five Asia-Pacific countries during the first wave of the COVID-19 pandemic: Mitigation strategies and epidemiology outcomes
-
Travel Med Infect Dis.
Located in
Teams
/
Vanhems P - PHE3ID
/
Actualités
-
Farnesoid X receptor alpha ligands inhibit HDV in vitro replication and virion infectivity.
-
Legrand AF, Lucifora J, Lacombe B, Ménard C, Michelet M, Foca A, Abrial P, Salvetti A, Rivoire M, Lotteau V, Durantel D, André P, Ramière C.
Hepatol Commun. 2023 Apr 14;7(5):e0078.
Located in
Teams
/
VIDALAIN PO - VIRIMI
/
News
-
Farnesoid X receptor alpha ligands inhibit hepatitis delta virus in vitro replication and virion infectivity
-
Legrand, Lucifora et al., Hepatology Communications, 2023 / Team VIRIMI and Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
Generation of a C57BL/6J mouse strain expressing the CD45.1 epitope to improve hematopoietic stem cell engraftment and adoptive cell transfer experiments
-
Laubreton D, Djebali S, Angleraux C, Chain B, Dubois M, Henry F, Leverrier Y, Teixeira M, Markossian S, Marvel J.
Located in
Teams
/
Marvel J - ICL
/
Actualités
-
Identification of a novel antiviral factor that reorganises Microtubules
-
Trim69 is a microtubule regulator that acts as a pantropic viral inhibitor
Yuxin Song, Xuan-Nhi Nguyen, Anuj Kumar, Claire da Silva, Léa Picard, Lucie Etienne and Andrea Cimarelli. Just published on PNAS https://doi.org/10.1073/pnas.2211467119
Located in
Teams
/
Cimarelli A - LP2L
/
News
-
Immunogenicity and efficacy of heterologous ChAdOx1–BNT162b2 vaccination
-
Pozzeto et al. Nature. December 2021
Located in
Teams
/
Paul S - GIMAP
/
Actualités
-
Inducers of the NF-κB pathways impair Hepatitis Delta virus (HDV) replication & strongly decrease progeny infectivity in vitro
-
Michelet, Alfaiate, Chardès et al., J Hep Reports, 2022 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against HBV
-
Lamrayat et al., Antiviral Research, 2023 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
-
Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients
-
by X.Charmetant, M.Espi (...) and O.Thaunat, Science Translational Medicine 2022 DOI : 10.1126/scitranslmed.abl6141
Located in
Teams
/
Thaunat O - NOPAB
/
Actualités
-
Inhibitory Effect of IL-1b on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages
-
Delphin et al., Viruses, 2022 / Team HepVir
Located in
Teams
/
Durantel D - HepVir
/
What's new for us?
